555 CB-5083, a first in class inhibitor of the AAA-ATPase...

European Journal of Cancer 2014 / 11 Vol. 50

555 CB-5083, a first in class inhibitor of the AAA-ATPase p97/VCP, induces irresolvable ER stress that results in antitumor activity in solid and hematological tumor models

Yakes, F., Le Moigne, R., Wong, S., Anderson, D.J., Djakovic, S., Valle, E., Menon, M.K., Rice, J., Yao, B., Soriano, F., Wang, J., von Soly, S. Kiss, Chesi, M., Bergsagel, P.L., Zhou, H.J., Rolfe, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70681-1
Date:
November, 2014
File:
PDF, 55 KB
english, 2014
Conversion to is in progress
Conversion to is failed